VitaNova Life Sciences (VNOV) Long-Term Deferred Tax (2018 - 2026)

VitaNova Life Sciences' Long-Term Deferred Tax history runs 9 years deep, the most recent figure standing at $98161.0 for Q1 2026.

• Quarterly Long-Term Deferred Tax rose 8.09% year-over-year to $98161.0 in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $98161.0 (up 8.09% YoY) and the FY2025 annual result came in at $102611.0, up 118.47% from the prior year.
• Long-Term Deferred Tax was $98161.0 for Q1 2026 at VitaNova Life Sciences, down from $147929.0 in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $147929.0 in Q4 2025 and bottomed at $1813.0 in Q4 2022.
• A 5-year average of $70504.1 and a median of $72876.0 in 2022 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax slumped 89.45% — and 2025, when it surged 118.47%.
• VitaNova Life Sciences' Long-Term Deferred Tax stood at $1813.0 in 2022, then soared by 1616.11% to $31113.0 in 2023, then soared by 153.55% to $78887.0 in 2024, then jumped by 87.52% to $147929.0 in 2025, then plunged by 33.64% to $98161.0 in 2026.
• Business Quant data shows VNOV's Long-Term Deferred Tax at $98161.0 in Q1 2026, $147929.0 in Q4 2025, and $120008.0 in Q3 2025.